Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 6,000 shares at $5.67 ($34K) on 2016-05-27, disclosed to the SEC on 2016-05-31.
Open-market purchase of $34k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |